KinoDyn

About:

KinoDyn is a cancer drug discovery company.

Description:

KinoDyn is a cancer drug discovery company that builds proprietary technology using multiplexed inhibitor beads and mass spectroscopy. The technology simultaneously maps and quantifies important cellular enzymes and kinases and determines their kinome-wide response to targeted therapeutics. It also focused on challenging cancers, including triple-negative breast cancer, pancreatic cancer, drug-resistant leukemias, and glioblastoma.

Total Funding Amount:

$550000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Chapel Hill, North Carolina, United States

Founded Date:

2013-01-01

Founders:

Gary Johnson, Jian Jin, Lee M Graves, Nathan P. Letts

Number of Employees:

1-10

Last Funding Date:

2014-06-19

IPO Status:

Private

Industries: